BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iorember F, Nayak A. Deficiency of CFHR plasma proteins and autoantibody positive hemolytic uremic syndrome: treatment rationale, outcomes, and monitoring. Pediatr Nephrol 2021;36:1365-75. [PMID: 32529325 DOI: 10.1007/s00467-020-04652-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Prokopenko EI. Atypical hemolytic-uremic syndrome: evolution of treatment and impact of clinical and genetic characteristics on possibility of eculizumab withdrawal. Nefrologiâ (St -Peterbg ) 2022;26:19-29. [DOI: 10.36485/1561-6274-2022-26-3-19-29] [Reference Citation Analysis]